Aug. 12 at 5:56 PM
$EVER is riding high above its 200-day SMA, but is it a buy? 📈
Despite a 43.2% upside potential to the
$34 target, EVER's expensive valuation, rising expenses, regulatory risks, and competition pose challenges in a competitive market. ⚖️
Discover the full analysis here 👉 https://www.zacks.com/stock/news/2702925/everquote-trades-above-200-day-sma-time-to-buy-the-stock?cid=sm-stocktwits-2-2702925-body-7498&ADID=SYND_STOCKTWITS_TWEET_2_2702925_BODY_7498